Published in Infect Immun on January 01, 1984
Contribution of immunoglobulin-secreting cells in the murine small intestine to the total 'background' immunoglobulin production. Immunology (1987) 1.75
Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine. Infect Immun (1987) 1.20
Secretory immunoglobulin A response following peroral priming and challenge with Shigella flexneri lacking the 140-megadalton virulence plasmid. Infect Immun (1986) 0.99
Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. Infect Immun (1994) 0.98
Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri. Infect Immun (1988) 0.91
Effect of parenteral immunization on the intestinal immune response to Salmonella typhi Ty21a. Infect Immun (1992) 0.87
Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity. Infect Immun (1995) 0.83
Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization. Immunology (1989) 0.79
Deficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during suckling. Infect Immun (1994) 0.77
Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med (1975) 5.02
The origin and antigen-dependent distribution of IgA-containing cells in the intestine. J Exp Med (1978) 4.01
Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin. J Exp Med (1969) 3.79
The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats. J Exp Med (1978) 2.94
Special features of the priming process for a secretory IgA response. B cell priming with cholera toxin. J Exp Med (1981) 2.00
Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C (1978) 1.86
Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats. J Immunol (1982) 1.81
Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats. J Immunol (1980) 1.73
Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load. J Exp Med (1979) 1.72
Direct demonstration in intestinal secretions of an IgA memory response to orally administered Shigella flexneri antigens. J Immunol (1982) 1.46
Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin. Infect Immun (1982) 1.36
Suppression of local intestinal immunoglobulin A immune response to cholera toxin by subcutaneous administration of cholera toxoids. Infect Immun (1979) 1.23
Cellular dissemination of priming for a mucosal immune response to cholera toxin in rats. J Immunol (1981) 1.22
Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect Immun (1980) 1.19
Genital antibody response to a parenteral gonococcal pilus vaccine. Infect Immun (1982) 1.14
Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response. J Immunol (1983) 0.99
Systemic priming of the secretory antibody response with soluble and particulate antigens and carriers. J Immunol (1982) 0.97
Intestinal immune response to cholera toxin: dependence on route and dosage of antigen for priming and boosting. Infect Immun (1980) 0.88
Suppression of the intestinal immune response to cholera toxin by specific serum antibody. Infect Immun (1980) 0.87
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Quality of hospital care for seriously ill children in less-developed countries. Lancet (2001) 7.08
Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med (1975) 5.02
Vibrio cholerae enterotoxin and its mode of action. Bacteriol Rev (1971) 4.98
Stimulation of jejunal secretion by a crude Escherichia coli enterotixin. Gastroenterology (1972) 4.02
Cholera in Africa: lessons on transmission and control for Latin America. Lancet (1991) 3.36
M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis (1986) 3.32
Deactivation of cholera toxin by ganglioside. J Infect Dis (1971) 3.16
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats. J Exp Med (1978) 2.94
Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis (1974) 2.73
Effect of intragastric glucose-electrolyte infusion upon water and electrolyte balance in Asiatic cholera. Gastroenterology (1968) 2.51
Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum. Gastroenterology (1971) 2.39
Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli. J Exp Med (1973) 2.38
Stimulation of glycerol production in fat cells by cholera toxin. Nature (1970) 2.34
Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med (1969) 2.28
Effect of Escherichia coli on fluid transport across canine small bowel. Mechanism and time-course with enterotoxin and whole bacterial cells. J Clin Invest (1973) 2.25
Acute undifferentiated human diarrhea in the tropics. II. Alterations in intestinal fluid and electrolyte movements. J Clin Invest (1971) 2.22
Protection against experimental cholera by antitoxin. J Infect Dis (1972) 2.21
Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis (1977) 2.13
Experimental cholera. A canine model. Lancet (1966) 1.88
Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect Immun (1982) 1.87
Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera. Infect Immun (1978) 1.84
Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats. J Immunol (1982) 1.81
Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ (1992) 1.74
Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats. J Immunol (1980) 1.73
Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization. J Immunol (1974) 1.73
Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect Immun (1983) 1.67
Water and electrolyte losses due to cholera in infants and small children: a recovery balance study. Pediatrics (1970) 1.64
Controlled comparison of tetracycline and furazolidone in cholera. Br Med J (1968) 1.59
Optimal antibiotic therapy in cholera. Bull World Health Organ (1968) 1.58
Oral fluid--a simple weapon against dehydration in diarrhoea: how it works and how to use it. WHO Chron (1977) 1.53
Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits. Infect Immun (1985) 1.51
Intestinal antibodies. J Infect Dis (1978) 1.48
The current status of oral therapy in the treatment of acute diarrheal illness. Am J Clin Nutr (1978) 1.43
Efficacy of rice-based oral rehydration. Lancet (1996) 1.40
Probable gallbladder infection in convalescent cholera patients. Lancet (1967) 1.39
Preliminary results of a study of small intestinal water and solute movement in acute and convalescent human cholera. Indian J Med Res (1968) 1.32
Challenge of dogs with live enterotoxigenic Escherichia coli and effects of repeated challenges on fluid secretion in jejunal Thiry-Vella loops. J Infect Dis (1976) 1.30
Gastric acidity in cholera and noncholera diarrhoea. Bull World Health Organ (1972) 1.23
Convalescent carriers of Vibrio cholerae. Detection and detailed investigation. Ann Intern Med (1970) 1.23
Cellular dissemination of priming for a mucosal immune response to cholera toxin in rats. J Immunol (1981) 1.22
Antitoxic immunity to cholera in dogs immunized orally with cholera toxin. Infect Immun (1980) 1.21
Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine. Infect Immun (1987) 1.20
Immunity to experimental cholera. II. Secretory and humoral antitoxin response to local and systemic toxoid administration. J Infect Dis (1975) 1.20
Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera. Infect Immun (1983) 1.19
Is a low-osmolarity ORS solution more efficacious than standard WHO ORS solution? J Pediatr Gastroenterol Nutr (1994) 1.19
Rice-based oral rehydration solution for treating diarrhoea. Cochrane Database Syst Rev (2000) 1.15
Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid. Infect Immun (1977) 1.13
Clinical trials of improved oral rehydration salt formulations: a review. Bull World Health Organ (1994) 1.07
Management of acute diarrhea in children: lessons learned. Pediatr Infect Dis J (1993) 1.04
Immune response of the intestinal mucosa to cholera toxoid. J Infect Dis (1977) 1.02
Stimulation of glycogenolysis by purified cholera exotoxin in disrupted cells. Johns Hopkins Med J (1971) 1.02
Parenteral immunization causes antigen-specific cell-mediated suppression of an intestinal IgA response. J Immunol (1983) 0.99
The use of Ringer's lactate in the treatment of children with cholera and acute noncholera diarrhoea. Bull World Health Organ (1972) 0.98
Systemic effects of parenteral cholera enterotoxin in dogs. J Lab Clin Med (1972) 0.97
Intestinal immunization with soluble bacterial antigens: the example of cholera toxoid. Ciba Found Symp (1976) 0.97
Oral-rehydration therapy--the role of polymeric substrates. N Engl J Med (1988) 0.95
Disseminated Curvularia infection. Additional therapeutic and clinical considerations with evidence of medical cure. Arch Pathol Lab Med (1986) 0.92
Effect of protein deprivation on immunoregulatory cells in the rat mucosal immune response. Clin Exp Immunol (1985) 0.92
Indicator dilution studies in the small bowel of patients with cholera diarrhea. II. Comparisons of absorbable and "poorly absorbable" substances. Johns Hopkins Med J (1970) 0.91
Magnitude and duration of antitoxic response to human infection with Vibrio cholerae. J Infect Dis (1970) 0.91
Bacteriological studies of convalescent carriers of cholera vibrios. Indian J Med Res (1969) 0.89
Protein deprivation causes reversible impariment of mucosal immune response to cholera toxoid/toxin in rat gut. Nature (1979) 0.89
Compared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A- B+ mutant (Texas Star-SR) studied in adult rabbits. Infect Immun (1984) 0.87
Suppression of the intestinal immune response to cholera toxin by specific serum antibody. Infect Immun (1980) 0.87
Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin. Rev Infect Dis (1984) 0.87
The ventilatory response to acute base deficit in humans. Time course during development and correction of metabolic acidosis. Ann Intern Med (1970) 0.85
Oral immunization against experimental cholera: the role of antigen form and antigen combinations in evoking protection. Ann N Y Acad Sci (1983) 0.84
Titration of cholera enterotoxin and antitoxin in isolated fat cells. J Infect Dis (1970) 0.84
Efficacy of standard glucose-based and reduced-osmolarity maltodextrin-based oral rehydration solutions: effect of sugar malabsorption. Bull World Health Organ (1996) 0.84
Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes. Infect Immun (1984) 0.83
Studies of intestinal absorption using a marker perfusion technique in cholera and acute tropical gastroenteritis. J Assoc Physicians India (1968) 0.82
Disseminated Curvularia infection. Arch Pathol Lab Med (1986) 0.81
Indicator dilution studies in the small bowel of patients with cholera diarrhea. I. Jejunal flow--transit time--volume relationships. Johns Hopkins Med J (1970) 0.81
WITHDRAWN: Rice-based oral rehydration solution for treating diarrhoea. Cochrane Database Syst Rev (2007) 0.80
Relation of ventilation during base deficit to acid-base values in blood and spinal fluid. J Appl Physiol (1971) 0.79
Oral maintenance of water-electrolyte and acid-base balance in cholera: a preliminary report. Indian J Med Res (1968) 0.79
Net and unidirectional transmucosal flux of sodium and water in acute human diarrheal disease. J Lab Clin Med (1972) 0.78
Bacterial characteristics and follicle surface structure: their roles in Peyer's patch uptake and transport of Vibrio cholerae. Adv Exp Med Biol (1988) 0.77
Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med (2000) 0.75
Intestinal microflora in a chronic carrier of Vibrio cholerae. J Infect Dis (1970) 0.75
Rational home management of diarrhoea. Lancet (1995) 0.75
Cholera treatment. Lancet (1994) 0.75
Experimental E. coli diarrhea: effects of viable bacteria and enterotoxin. Trans Assoc Am Physicians (1973) 0.75
Hyperkalaemia and glucose/electrolyte solutions. Lancet (1980) 0.75
Oral replacement of water and electrolyte losses in cholera. Indian J Med Res (1969) 0.75
Conjunctival immunity: compared effects of ocular or intestinal immunization in rats. Invest Ophthalmol Vis Sci (1983) 0.75
Gastrointestinal intubation in ascariasis. N Engl J Med (1968) 0.75
Management of cholera in adults and children. Public Health Pap (1970) 0.75
From the National Institute of Allergy and Infectious Diseases. Summary of the 19th United States-Japan Joint Cholera Conference. J Infect Dis (1984) 0.75
The role of antigen form and the induction of an intestinal immune response to cholera toxin/toxoid in rats. Adv Exp Med Biol (1978) 0.75
How much has ORT reduced child mortality? J Health Popul Nutr (2001) 0.75
Oral solutions for cholera. Ann Intern Med (1969) 0.75
Oral electrolytes in cholera. Ann Intern Med (1970) 0.75
Recent advances in pathogenesis of diarrheal disease relation to treatment and prevention. Paediatr Indones (1972) 0.75